Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690

BMC Medical Research Methodology

Volumn 12, Issue , 2012, Pages

  Ibrahim, Joseph G ^a   Chen, Ming Hui ^b   Chu, Haitao ^c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cure rate model; Historical data; Posterior distribution; Prior distribution

Indexed keywords

ALPHA INTERFERON;

ARTICLE; BAYES THEOREM; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; HUMAN; MELANOMA; METHODOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SKIN TUMOR; STATISTICAL DISTRIBUTION; STATISTICS; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; HUMANS; INTERFERON-ALPHA; MELANOMA; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; STATISTICAL DISTRIBUTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84870063279     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-12-183     Document Type: Article

References (12)

1. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Berry D, Wathen JK, Newell M, Clinical Trials 2009 6 1 28 41 10.1177/1740774508101279 19254931
2. Berry SM, Carlin BP, Lee J, Muller P, Bayesian adaptive methods for clinical trials Boca Raton, FL: Chapman & Hall/CRC 2010
3. Gelman A, Carlin JB, Stern HS, Rubin DB, Bayesian data analysis Boca Raton, FL: Chapman & Hall/CRC 2 2004
4. Carlin BP, Louis TA, Bayesian methods for data analysis Boca Raton, FL: Chapman & Hall/CRC 3 2008
5. Ibrahim JG, Chen MH, Sinha D, Bayesian survival analysis New York: Springer 2001
6. Power prior distributions for regression models. Ibrahim JG, Chen MH, Stat Sci 2000 15 1 46 60 10.1214/ss/1009212673
7. Bayesian cure rate models for malignant melanoma: a case-study of Eastern Cooperative Oncology Group trial E1690. Chen MH, Harrington DP, Ibrahim JG, Journal of the Royal Statistical Society: Series C (Applied Statistics) 2002 51 2 135 150 10.1111/1467-9876.00259
8. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH, J Clin Oncol 1996 14 1 7 17 8558223 (Pubitemid 26019991)
9. High- and Low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, et al. J Clin Oncol 2000 18 12 2444 2458 10856105 (Pubitemid 30415832)
10. The large sample distribution of the weighted log rank statistic under general local alternatives. Ewell M, Ibrahim JG, Lifetime Data Anal 1997 3 5 12 10.1023/A:1009690200504 9384622 (Pubitemid 127479317)
11. A new Bayesian model for survival data with a surviving fraction. Chen MH, Ibrahim JG, Sinha D, J Am Statist Assoc 1999 94 909 919 10.1080/01621459. 1999.10474196
12. Bayesian case influence diagnostics for survival models. Cho H, Ibrahim JG, Sinha D, Shu H, Biometrics 2009 65 116 124 10.1111/j.1541-0420.2008.01037.x 18422991